Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer. [electronic resource]
Producer: 20150105Description: 241-7 p. digitalISSN:- 1473-1150
- ATP Binding Cassette Transporter, Subfamily B -- genetics
- Aldehyde Dehydrogenase -- genetics
- Aldehyde Dehydrogenase 1 Family
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Humans
- Multidrug Resistance-Associated Proteins -- genetics
- Polymorphism, Single Nucleotide
- Retinal Dehydrogenase
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.